AxoGen AXGN, today announced the presentation of data on AxoGen's Avance® Nerve Graft in four presentations, including updated data from the RANGER® Registry presented in a poster and podcast, at the American Society for Surgery of the Hand (ASSH) 2013 Meeting, taking place October 3-6 in San Francisco.
The RANGER® Registry is an on-going, multi-center, utilization and outcomes study for Avance® Nerve Graft, a processed nerve allograft for the repair and reconstruction of peripheral nerve defects. The RANGER® Registry update will be presented by study investigator Wesley P. Thayer, M.D., Ph.D., Assistant Professor, Department of Plastic Surgery and Department of Orthopaedic Surgery at Vanderbilt University Medical Center.
Erick DeVinney, Director of Clinical and Translational Sciences at AxoGen, said, “We are thrilled that AxoGen has a robust presence at the ASSH 2013 meeting, including updated data from the landmark RANGER® Registry by the investigators and several physician presentations on nerve repair in the hand using our products. The multiple sets of data reflect
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in